Ying Y - Search Results

1

FXR-regulated COX6A2 triggers mitochondrial apoptosis of pancreatic β-cell in type 2 diabetes.

Shao L, Kong X, Lv S, Shu X, Ma X, Ai X, Yan D, Ying Y. Shao L, et al. Among authors: ying y. Cell Death Dis. 2024 Dec 20;15(12):920. doi: 10.1038/s41419-024-07302-4. Cell Death Dis. 2024. PMID: 39702527 Free PMC article.

2

Increased COX6A2 promotes pancreatic β-cell apoptosis and is suppressed in diabetic GK rats after Roux-en-Y gastric bypass.

Kong X, Yan D, Shao L, Li B, Lv S, Tu Y, Zhang Y, Shu X, Ying Y, Ma X. Kong X, et al. Among authors: ying y. Diabetes. 2024 Nov 15:db240301. doi: 10.2337/db24-0301. Online ahead of print. Diabetes. 2024. PMID: 39546664

3

A distal super-enhancer activates oncogenic ETS2 via recruiting MECOM in inflammatory bowel disease and colorectal cancer.

Chen Y, Ying Y, Wang M, Ma C, Jia M, Shi L, Wang S, Zheng X, Chen W, Shu XS. Chen Y, et al. Among authors: ying y. Cell Death Dis. 2023 Jan 6;14(1):8. doi: 10.1038/s41419-022-05513-1. Cell Death Dis. 2023. PMID: 36609474 Free PMC article.

4

The microtubule associated protein syntabulin is required for glucose-stimulated and cAMP-potentiated insulin secretion.

Ying Y, Li L, Cao W, Yan D, Zeng Q, Kong X, Lu L, Yan M, Xu X, Qu J, Su Q, Ma X. Ying Y, et al. FEBS Lett. 2012 Oct 19;586(20):3674-80. doi: 10.1016/j.febslet.2012.08.025. Epub 2012 Sep 6. FEBS Lett. 2012. PMID: 22975310 Free article.

5

Targeted pharmacotherapy against neurodegeneration and neuroinflammation in early diabetic retinopathy.

Rolev KD, Shu XS, Ying Y. Rolev KD, et al. Among authors: ying y. Neuropharmacology. 2021 Apr 1;187:108498. doi: 10.1016/j.neuropharm.2021.108498. Epub 2021 Feb 12. Neuropharmacology. 2021. PMID: 33582150 Review.

6

GSK3β-mediated tau hyperphosphorylation triggers diabetic retinal neurodegeneration by disrupting synaptic and mitochondrial functions.

Zhu H, Zhang W, Zhao Y, Shu X, Wang W, Wang D, Yang Y, He Z, Wang X, Ying Y. Zhu H, et al. Among authors: ying y. Mol Neurodegener. 2018 Nov 22;13(1):62. doi: 10.1186/s13024-018-0295-z. Mol Neurodegener. 2018. PMID: 30466464 Free PMC article.

7

GLP1 protects cardiomyocytes from palmitate-induced apoptosis via Akt/GSK3b/b-catenin pathway.

Ying Y, Zhu H, Liang Z, Ma X, Li S. Ying Y, et al. J Mol Endocrinol. 2015 Dec;55(3):245-62. doi: 10.1530/JME-15-0155. Epub 2015 Sep 18. J Mol Endocrinol. 2015. PMID: 26386043 Free PMC article.

8

Loss of β-catenin via activated GSK3β causes diabetic retinal neurodegeneration by instigating a vicious cycle of oxidative stress-driven mitochondrial impairment.

Shu XS, Zhu H, Huang X, Yang Y, Wang D, Zhang Y, Zhang W, Ying Y. Shu XS, et al. Among authors: ying y. Aging (Albany NY). 2020 Jun 23;12(13):13437-13462. doi: 10.18632/aging.103446. Epub 2020 Jun 23. Aging (Albany NY). 2020. PMID: 32575075 Free PMC article.

9

Targeting cancer metabolic vulnerabilities for advanced therapeutic efficacy.

Muluh TA, Shu XS, Ying Y. Muluh TA, et al. Among authors: ying y. Biomed Pharmacother. 2023 Jun;162:114658. doi: 10.1016/j.biopha.2023.114658. Epub 2023 Apr 7. Biomed Pharmacother. 2023. PMID: 37031495 Free article. Review.

10

Topical ocular administration of the GLP-1 receptor agonist liraglutide arrests hyperphosphorylated tau-triggered diabetic retinal neurodegeneration via activation of GLP-1R/Akt/GSK3β signaling.

Shu X, Zhang Y, Li M, Huang X, Yang Y, Zeng J, Zhao Y, Wang X, Zhang W, Ying Y. Shu X, et al. Among authors: ying y. Neuropharmacology. 2019 Jul 15;153:1-12. doi: 10.1016/j.neuropharm.2019.04.018. Epub 2019 Apr 20. Neuropharmacology. 2019. PMID: 31015047

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,105 results

Search Page

Filters